Aquestive Therapeutics Inc. (AQST) Misses Q1 EPS by 8c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $12.23 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Patrick Industries (PATK) Reiterated at Buy by Benchmark amid Pressured NT Outlook
• DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised